(S)-T-Butylamino-1,2-Propanediol, often found listed with the HS Code 2922199090, stands out as a raw chemical material with clear significance in both pharmaceutical and fine chemical manufacturing. The name reveals its structure: a propanediol backbone, carrying an aminated side chain modified with a bulky t-butyl group, skewed to the S stereochemistry. From years in research and materials labs, I’ve seen firsthand that small changes to chemical structure can translate to big differences in behavior—something true for this compound, which appears in everything from blend intermediates to specialty pharma formulations.
The material formula C7H17NO2 points to a tightly organized structure. Its density usually lands in the neighborhood of 1.04-1.06 g/cm³ at room temperature, based on standard laboratory measurements. Drawing the molecule on paper or a modeling program, the t-butyl group branches off from the central chain, offering notable steric hindrance—a factor that alters reactivity and reduces undesired side reactions under typical laboratory conditions. With its two alcohol groups, the compound displays moderate water solubility, occasionally forming viscous solutions, especially as you approach higher concentrations.
On the benchtop, (S)-T-Butylamino-1,2-Propanediol typically lands in the solid state—ranging from white to slightly off-white, depending on batch purity. It comes as powder, coarse flakes, or sometimes crystalline pearls, always packed to limit air and moisture uptake. Controlled lab conditions keep material stable, but I’ve opened containers to discover slight caking if environmental humidity creeps up or if the compound sits for months undisturbed. Unlike many alkylamino alcohols, this compound resists deliquescence, so it rarely slumps into a sticky or liquid mess unless temperatures stray above 50°C for long periods. Working safely means gloves and splash goggles; dust or solution on bare skin could spark mild irritation, with the MSDS spelling out risks more sharply for prolonged contact.
(S)-T-Butylamino-1,2-Propanediol doesn’t land in consumer products—its value runs behind the scenes. You’ll find it feeding into active pharmaceutical ingredient synthesis, especially beta-blockers and related cardioselective drug intermediates. The compound’s structure lets chemists steer reaction pathways with precision, reducing the burden of purification and raising process yield. While on shift in pharma production, I saw engineers focus on batch control, since impurities in these raw material stages can ripple down to finished drug safety, a topic that’s never left the headlines for long.
In handling bulk shipments or kilogram-scale packs, safe practice never fades into the background. This compound, though safer than many chemical reagents, carries enough irritative and harmful potential that storage and transport demand tightly sealed containers and accurate labeling under international guidelines. Efforts to move toward greener chemistry have spurred suppliers to deliver more comprehensive data on residual solvents, allergenic cross-contaminants, and biodegradability. Disposal, from my experience in regulated environments, always goes through certified waste routines—much better than taking shortcuts, since chemical residues of (S)-T-Butylamino-1,2-Propanediol wash out poorly in municipal treatment and threaten aquatic microfauna if ignored.
Every kilogram that leaves a warehouse ties modern drug development to reliable sourcing, tight quality controls, and international regulatory frameworks. The molecular formula and its stereochemistry are essential, as the physical and pharmacological properties split sharply between enantiomers, so vendors face pressure to supply optical rotation certificates on every batch. The EU, US, and East Asia all recognize the importance of clear hazard communication—resulting in harmonized SDS documents, batch-level CoAs, and robust cross-checks of analytic data. In my regulatory work, stakeholders pressed for better traceability, often insisting on blockchain verification or third-party audits to stay ahead of recalls and compliance headaches.
Looking to the future, the industry trends lean toward lower energy syntheses, greener solvents, and continuous-flow manufacturing—projected to influence compounds like (S)-T-Butylamino-1,2-Propanediol. As researchers chase improvements in yield and cut hazardous waste, suppliers answer back with new methods, like biocatalytic amination or recyclable purification media. This shift, slowly finding its footing, could soon reduce risks both for plant operators and communities around production sites.
Chemicals like (S)-T-Butylamino-1,2-Propanediol remind us that every material on the supply chain—no matter how obscure its name—shapes safety, quality, and the future pace of medical breakthroughs. Working with such materials means staying alert: knowing MSDS data by heart, never skipping on PPE, documenting every batch, and keeping environmental stewardship as a guiding principle. The details behind a chemical name don’t always grab front-page news, but for anyone with hands in real-world labs and production, these details make all the difference.